SCHEMBL18594385

SCHEMBL18594385

CC[C@H]1C[C@H]1C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11243243 1.00 — —
SCHEMBL14295531 0.85 — —
SCHEMBL15502041 0.80 — —
SCHEMBL19242737 0.80 — —
SCHEMBL12834104 0.80 — —
SCHEMBL5441693 0.79 — —
SCHEMBL22909964 0.77 — —
SCHEMBL20663904 0.74 — —
SCHEMBL12394120 0.74 — —
SCHEMBL24512614 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170057928-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GILEAD SCIENCES, INC. 2017-03-02 — — US disclosed
Send feedback